Nebraska will become the first state to implement new work requirements for some people with Medicaid health insurance under a law President Donald Trump signed last year.

President Donald Trump signed an executive order Thursday that could reclassify marijuana as a less dangerous drug and open new avenues for medical research, a major shift in federal drug policy that inches closer to what many states have done.

President Donald Trump, on December 18, signed an executive order directing the reclassification of marijuana from a Schedule I to Schedule III controlled substance at the federal level.

Mr. Trump also authorized a pilot program to reimburse Medicare patients for products made with CBD, a popular, non-psychoactive compound of cannabis.

President Donald Trump is anticipated to announce a pilot program that would reimburse Medicare patients for CBD treatments, according to a Thursday report in The Washington Post.

U.S. President Donald Trump on Thursday said he would sign an order recommending the loosening of federal regulations on marijuana, a move that could further reverse decades of tough-on-weed policy.

The decision to reclassify cannabis as a less dangerous drug does not legalize cannabis, but eases the operating environment for companies by improving access to capital, reducing tax burden and accel...